Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie et al. Issue 1 (22nd June 2020)

Record Type:: Journal Article
Title:: Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie et al. Issue 1 (22nd June 2020)
Main Title:: Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie et al
Authors:: Gamboa-Alonso, Carmen Magdalena
Figueroa-Parra, Gabriel
Galarza-Delgado, Dionicio Angel
Abstract:
Is Part Of:: Annals of the rheumatic diseases. Volume 80:Issue 1(2021)
Journal:: Annals of the rheumatic diseases
Issue:: Volume 80:Issue 1(2021)
Issue Display:: Volume 80, Issue 1 (2021)
Year:: 2021
Volume:: 80
Issue:: 1
Issue Sort Value:: 2021-0080-0001-0000
Page Start:: e7
Page End:: e7
Publication Date:: 2020-06-22
Subjects:: antirheumatic agents -- arthritis, rheumatoid -- autoimmune diseases -- hydroxychloroquine -- lupus erythematosus, systemic
Rheumatism -- Periodicals
616.723005
Journal URLs:: http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗
DOI:: 10.1136/annrheumdis-2020-217633 ↗
Languages:: English
ISSNs:: 0003-4967
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 17313.xml